JFG
WST icon

Jefferies Financial Group’s West Pharmaceutical WST Stock Holding History

Jefferies Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51M Sell
9,764
-5,111
-34% -$1.56M 0.02% 493
2026
Q1 		$3.73M Sell
14,875
-15,001
-50% -$3.73M 0.03% 410
2025
Q4 		$8.22M Sell
29,876
-8,869
-23% -$2.43M 0.04% 373
2025
Q3 		$10.2M Buy
38,745
+1,500
+4% +$365K 0.05% 237
2025
Q2 		$8.15M Buy
37,245
+18,033
+94% +$3.85M 0.07% 205
2025
Q1 		$4.3M Sell
19,212
-14,814
-44% -$4.08M 0.04% 337
2024
Q4 		$11.1M Buy
34,026
+25,845
+316% +$8.13M 0.07% 206
2024
Q3 		$2.46M Buy
8,181
+5,498
+205% +$1.68M 0.02% 528
2024
Q2 		$884K Sell
2,683
-9,022
-77% -$3.19M 0.01% 794
2024
Q1 		$4.63M Buy
11,705
+2,005
+21% +$742K 0.04% 324
2023
Q4 		$3.42M Buy
9,700
+1,300
+15% +$460K 0.02% 515
2023
Q3 		$3.15M Buy
8,400
+5,520
+192% +$2.13M 0.03% 474
2023
Q2 		$1.1M Sell
2,880
-1,920
-40% -$686K 0.01% 874
2023
Q1 		$1.66M Buy
+4,800
New +$1.4M 0.01% 722

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Jefferies Financial Group's WST Position: Q2 2026 in Review

Jefferies Financial Group reduced its West Pharmaceutical (WST) stake by 34% in Q2 2026, selling an estimated $1.56M and leaving 9,764 shares worth $3.51M. The position accounts for 0.02% of the portfolio, ranked #493.

Jefferies Financial Group first reported a position in WST in Q1 2023 and has held it in 14 quarters since. The position peaked at $11.1M in Q4 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Jefferies Financial Group held 9,764 shares of West Pharmaceutical worth $3.51M as of Q2 2026.
  • Jefferies Financial Group sold 5,111 West Pharmaceutical shares in Q2 2026, an estimated $1.56M.
  • West Pharmaceutical made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #493 holding.
  • Jefferies Financial Group first reported a position in West Pharmaceutical in Q1 2023 and has held it in 14 quarters since.
  • Jefferies Financial Group's West Pharmaceutical position peaked at $11.1M in Q4 2024.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.